Blog

Discover our latest articles and blogs

Secure Biotech Seed Funding Steps: A Founder Playbook
August 20, 2026

Secure Biotech Seed Funding Steps: A Founder Playbook

Unlock the secrets to secure biotech seed funding with essential steps. Prepare your team, budget wisely, and approach investors effectively.

What Is Seed Stage Biotech Funding for Founders?
August 19, 2026

What Is Seed Stage Biotech Funding for Founders?

Discover how seed stage biotech funding helps founders secure crucial capital, transforming early findings into viable drug development pathways.

How Biotech Licensing Deals Are Structured
August 18, 2026

How Biotech Licensing Deals Are Structured

Learn how biotech licensing deals are structured to maximize value, from upfront payments to royalties, ensuring successful negotiations.

What Drives a Biotech Series B Valuation
August 17, 2026

What Drives a Biotech Series B Valuation

Discover the key factors that drive biotech Series B valuations, including clinical results, regulatory designations, and market potential.

How Biotech IPO Readiness Is Assessed: A Founder's Playbook
August 16, 2026

How Biotech IPO Readiness Is Assessed: A Founder's Playbook

Discover how to assess biotech IPO readiness in six key areas. Ensure your company is prepared to begin the S-1 filing process.

Biotech Liquidity Event Timeline: A Founder's Guide
August 15, 2026

Biotech Liquidity Event Timeline: A Founder's Guide

Discover the essential timeline for biotech liquidity events, from M&A to IPOs, and learn how to prepare effectively for success.

Why Biotech Boards Prioritize Time Savings: A Playbook
August 14, 2026

Why Biotech Boards Prioritize Time Savings: A Playbook

Discover why biotech boards must prioritize time savings to enhance valuation, investor options, and competitive edge in drug development.

Probability of Success in Biotech: What It Really Means
August 13, 2026

Probability of Success in Biotech: What It Really Means

Uncover the true meaning of probability of success in biotech, its impact on investments, and key insights that guide decisions.

Why Operational Transparency Matters to Biotech Investors
August 12, 2026

Why Operational Transparency Matters to Biotech Investors

Discover why operational transparency is essential for biotech investors. It influences trust, risk assessment, and deal-making speed.